125 related articles for article (PubMed ID: 6927369)
1. [Immunogenicity of cancer-associated and cancer-specific antigens].
del Pozo AM; Valladares Y; Alvarez-Rodríguez Y; Alvarez-Noves J
Rev Esp Oncol; 1982; 29(4):685-700. PubMed ID: 6927369
[TBL] [Abstract][Full Text] [Related]
2. [Method of isolation of cancer-associated and cancer-specific antigens].
del Pozo AM; Valladares Y; Alvarez-Rodríguez Y; Alvarez-Noves J
Rev Esp Oncol; 1982; 29(4):675-84. PubMed ID: 6765421
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the antigenic specificity of cell subpopulations of Ehrlich ascites cancer].
Lobko GN; Porubova GM
Eksp Onkol; 1989; 11(1):69-71. PubMed ID: 2466634
[TBL] [Abstract][Full Text] [Related]
4. [Study of indirect active immunotherapy of Ehrlich carcinoma].
De Santana CF; Da Silva IN
Rev Inst Antibiot (Recife); 1974 Dec; 14(1-2):3-8. PubMed ID: 4471334
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
Saha S; Mondal S
Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
[TBL] [Abstract][Full Text] [Related]
6. Exogenous DNA transcription in cells with their native DNA inhibited. 4. Demonstration of specific antigens codified by exogenous DNA.
Alvarez-Rodriguez Y; Alvarez-Noves J; Valladares Y; del Pozo M
Cytobios; 1982; 34(135-36):191-206. PubMed ID: 6293773
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of Ehrlich ascites carcinoma (EAC) with antiserum to modified EAC.
Das AK; Roy DK
Indian J Exp Biol; 1985 Nov; 23(11):641-3. PubMed ID: 3833682
[No Abstract] [Full Text] [Related]
8. Augmented immunogenicity of tumor cell homogenates produced by infection with influenza virus.
Boone CW
Natl Cancer Inst Monogr; 1972 Dec; 35():301-7. PubMed ID: 4349150
[No Abstract] [Full Text] [Related]
9. Antibody formation for malignant tumor. II. Antigenicity of Ehrlich ascites tumor lipoprotein.
Yamamoto Y; Tadatomo Y; Okamura S
Acta Med Okayama (1952); 1970 Oct; 24(5):527-36. PubMed ID: 4256471
[No Abstract] [Full Text] [Related]
10. Antibody formation for malignant tumor. 3. Antigenicity of peptide of ribosomal digest in Ehrlich ascites tumor.
Yamamoto Y; Jituiki D; Yabuki Y
Acta Med Okayama (1952); 1970 Oct; 24(5):534-7. PubMed ID: 4256472
[No Abstract] [Full Text] [Related]
11. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
Culo F; Marić M; Morović-Vergles J
In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
Saha S; Mondal S
J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
[TBL] [Abstract][Full Text] [Related]
13. Long-term caffeine consumption reverses tumor-induced suppression of the innate immune response in adult mice.
Mandal A; Poddar MK
Planta Med; 2008 Dec; 74(15):1779-84. PubMed ID: 19016405
[TBL] [Abstract][Full Text] [Related]
14. [Stimulation of cell division by Ehrlich carcinoma cell surface antibodies].
Segarra M; Alfonso M; Subiza JL; Coll J
Rev Esp Oncol; 1984; 31(2):205-13. PubMed ID: 6443683
[TBL] [Abstract][Full Text] [Related]
15. Immunization of mice against transplantable tumor.
Kay ER
Experientia; 1973 Jun; 29(6):710-1. PubMed ID: 4718721
[No Abstract] [Full Text] [Related]
16. Does caffeine reverse the EAC cell-induced immune suppression?
Mandal A; Poddar MK
J Pharm Pharmacol; 2007 Jul; 59(7):1001-9. PubMed ID: 17637196
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro.
Dürrbach A; Angevin E; Poncet P; Rouleau M; Chavanel G; Chapel A; Thierry D; Gorter A; Hirsch R; Charpentier B; Senik A; Hirsch F
Cancer Gene Ther; 1999; 6(6):564-71. PubMed ID: 10608353
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
Sur P; Roy DK
Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
[No Abstract] [Full Text] [Related]
19. Surface antigen on Ehrlich ascites tumor cells.
Pessina A; Brambilla P; Mocarelli P
Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
[TBL] [Abstract][Full Text] [Related]
20. Rejection of lethal tumors after subcutaneous inoculation: a phenomenon of antigenic expression?
Apffel CA; Peters JH
J Natl Cancer Inst; 1967 Dec; 39(6):1129-39. PubMed ID: 4170428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
